• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018
  • New Vizit Bibliography pane January 8, 2018
  • Share to Weibo added to Biovista Vizit October 25, 2017

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

FAECALIBACTERIUM PRAUSNITZII

TNF inhibitors and the microbiome

August 24, 2018Autoimmune Diseases, Microbiome, Vizit Graphs
TNF inhibitors and the microbiome

Study microbiota of patients treated with TNF inhibitors with Biovista Vizit. Explore the live graph.

Vizit Graphs Tag Cloud

CANCER LISTERIA MONOCYTOGENES TP53 INSULIN TH17 CELLS IFNG INFLAMMATION IL23A RHEUMATOID ARTHRITIS RECEPTOR STAPHYLOCOCCUS AUREUS AGING ESCHERICHIA COLI IL17A DOXORUBICIN CELL PROLIFERATION DIABETES MELLITUS AUTOPHAGY IMMUNE RESPONSE METFORMIN FOXP3 CLOSTRIDIUM DIFFICILE TNF ERBB-2 STREPTOCOCCUS PNEUMONIAE IL6 PORPHYROMONAS GINGIVALIS HELICOBACTER PYLORI CELL DIFFERENTIATION CD4 ALZHEIMER'S DISEASE APOPTOTIC PROCESS CASP3 REMICADE BREAST CANCER NEURODEGENERATIVE DISORDERS PARKINSON DISEASE CANDIDA ALBICANS PSEUDOMONAS AERUGINOSA 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE CELL DIVISION CELL DEATH ANGIOGENESIS SOD1 CTLA4

© 2019 Biovista Vizit All Rights Reserved.